Evidence map›Paper›PMID 42396463›Full record

ArticleFrontiers in immunology2026

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.

Hui Wang, Jun Li, Yinghai Wang, Yuebin Shi, Peiren Tang, Ying Li, Jiang Gu, Li Wang

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui Wang *Department of Pathology, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China.
Jun Li *Sample Biobank, National Biobank of China, Shenzhen Medical Academy of Research and Translation (SMART), Shenzhen, China.
Yinghai Wang *Department of Gynecology, Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Yuebin Shi *Department of Pathology, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China.
Peiren TangDepartment of Pathology, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China.
Ying LiDepartment of Pathology, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China.
Jiang GuProvincial Key Laboratory of Molecular Pathology and Personalized Medicine Center of Collaborative and Creative Center, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, China.
Li WangDepartment of Pathology, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In previous studies, we identified the unique tumor immunosuppressive function of IgG4. This study aims to further characterize the structure of IgG4 and evaluate its potential effects on monocyte-derived dendritic cells (moDCs). Methods: The densities of IgG4 and CD11c in esophageal cancer tissues were detected by immunohistochemistry. IgG1 and IgG4 subclasses were purified from IgG1 and IgG4 subclasses were purified from intravenous immunoglobulin (IVIg) and human serum samples using subclass‑specific affinity chromatography. Human peripheral CD14⁺ monocytes were isolated and induced to differentiate into moDCs Results: Immunohistochemical staining revealed that the densities of IgG4⁺ and CD11c⁺ cells were significantly higher in esophageal squamous cell carcinoma (ESCC) tissues than in adjacent normal tissues. Protein electrophoresis, molecular weight analysis, lectin affinity chromatography, and spectrometry demonstrated that native IgG4 exhibits distinct glycosylation profiles compared with IgG1 or commercial myeloma-derived IgG4. IgG4 was predominantly enriched in the ConA⁺ IgG fraction, indicating that it undergoes extensive high-mannose glycosylation. Immunocytochemical staining revealed that peripheral blood-derived monocytes expressed CD68 and CD206, and displayed strong binding affinity for IgG1 but weak affinity for IgG4. Discussion: Collectively, these findings suggest that IgG4-associated glycosylation features may be linked to altered phenotypic and functional parameters of moDCs in this exploratory

Indexed as

Dendritic CellsEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaImmunoglobulin GMonocytesCD11c AntigenCell DifferentiationCell MovementFemaleGlycoproteinsGlycosylationHumansMaleMiddle AgedPhagocytosisCD11c AntigenGlycoproteinsglycosylated IgGImmunoglobulin Gdendritic celldifferentiationglycosylationimmunoglobulin G1immunoglobulin G4

Identifiers

PMID42396463
PMCPMC13323231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.